Mirtazapine and mefloquine therapy for non–AIDS-related progressive multifocal leukoencephalopathy

Wisconsin Medical Journal

Volumn 113, Issue 6, 2014, Pages 242-245

  Epperla, Narendranath ^a   Medina Flores, Rafael ^a   Mazza, Joseph J ^a   Yale, Steven H ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; FOSPHENYTOIN SODIUM; MEFLOQUINE; METRONIDAZOLE; MIRTAZAPINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; MIANSERIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGED; ARTICLE; BRAIN ABSCESS; BRAIN BIOPSY; CASE REPORT; CEREBROSPINAL FLUID; CHRONIC LYMPHATIC LEUKEMIA; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; EDEMA; FLOW CYTOMETRY; FRONTAL LOBE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; JC VIRUS; LYMPHOCYTIC INFILTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSYCHOMOTOR DISORDER; SEIZURE; SPLENECTOMY; SPLENOMEGALY; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; DRUG COMBINATION; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; DRUG THERAPY, COMBINATION; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MEFLOQUINE; MIANSERIN;

EID: 84919776472     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Albrecht H, Hoffmann C, Degen O, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998;12(10):1149-1154.
2. Aksamit AJ. Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 2001;7(4):386-390.
3. Vulliemoz S, Lurati-Ruiz F, Borruat FX, et al. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry. 2006;77(9):1079-1082.
4. Verma S, Cikurel K, Koralnik IJ, et al. Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis. 2007;196(5):709- 711.
5. Owczarczyk K, Hilker R, Brunn A, Hallek M, Rubbert A. Progressive multifocal leucoencephalopathy in a patient with sarcoidosis--successful treatment with cidofovir and mirtazapine. Rheumatology (Oxford). 2007;46(5):888-890.
6. Terrier B, Hummel A, Fakhouri F, et al. [Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir]. [Article in French] Rev Med Interne. 2007;28(7):488-491.
7. De Raedt S, Lacor P, Michotte A, Flamez A, Ebinger G. Progressive multifocal leukoencephalopathy as first manifestation of sarcoidosis. Clin Neurol Neurosurg. 2008;110(2):186-189.
8. Yagi T, Hattori H, Ohira M, et al. Progressive multifocal leukoencephalopathy developed in incomplete Heerfordt syndrome, a rare manifestation of sarcoidosis, without steroid therapy responding to cidofovir. Clin Neurol Neurosurg. 2010;112(2):153- 156.
9. Schröder A, Lee DH, Hellwig K, Lukas C, Linker RA, Gold R. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol. 2010;67(11):1391-1394.
10. Berger JR, Pall L, Lanska D, Witeman M: Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neuroviro/1998,4:S9-68.
11. Aksamit AJ: Nonradioactive in situ hybridization in progressive multifocal leukoencephalopathy. Mayo Clin Proc. 1993, 68:899-910.
12. Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984;2(2):299-313.
13. Aksamit AJ. Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol. 2008,10(3):178-185.
14. Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 1993;187(1):233-240.
15. Bossolasco S, Calori G, Moretti F, et al. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis. 2005;40(5):738-744.
16. Aksamit AJ. Progressive multifocal leukoencephalopathy: a review of pathology and pathogenesis. Microsc Res Tech. 1995;32(4):302-311.
17. Berenguer J, Miralles P, Arrizabalaga J, et al. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis. 2003;36(8):1047-1052.
18. Khanna N, Elzi L, Mueller NJ, et al. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis. 2009;48(10):1459-1466.
19. Khanna N, Wolbers M, Mueller NJ, et al. JCV-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol. 2009;83(9):4404-4411.
20. Aksamit AJ. Review of progressive multifocal leukoencephalopathy and natalizumab. Neurologist. 2006;12(6):293-298.
21. Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306(5700):1380-1383.
22. Brickelmaier M, Lugovskoy A, Kartikeyan R, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother. 2009;53(5):1840-1849.
23. Kishida S, Tanaka K. Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. Intern Med. 2010;49(22):2509-2513.
24. Gofton TE, Al-Khotani A, O'Farrell B, Ang LC, McLachlan RS. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2011;82(4):452-455.
25. Beppu M, Kawamoto M, Nukuzuma S, Kohara N. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med. 2012;51(10):1245-1247.
26. Friedman R. News from the AAN Annual Meeting: malaria drug fails to fulfill promise in PML. Neurology Today. 2011;11:8.